CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...

A recent White House executive order could make it harder for millions of Americans to access their lifesaving medications.

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

American children’s health has declined profoundly over the past few decades, a new study shows, and the issues are so ...

Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.

Scientists and public health advocates see disconnects between what the Trump administration says about health — notably, in ...

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

Public health leaders say the nation can no longer afford to treat illness after it appears and today released a bold new report, Healthy Longevity: Public Health’s Next Frontier, calling for ...

The insurer can deny your claim at the time of medical emergency if you have not disclosed your medical history with the ...

Its causes are too numerous to list. It can cripple a person’s body, state of mind, bank account, quality of life, and job ...

Minister of Health and Wellness Dr. Michael Darville said yesterday that a bill that would integrate the prescription drug ...